Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
Received: 18 December 2020
Accepted: 7 June 2021
First Online: 22 June 2021
: Upon installation, M-sense users agree to the use of their data in anonymous form for research purposes.
: BR reports research grants from Novartis, and personal fees from Hormosan, Novartis, Teva, and Allergan. JM reports personal fees from Novartis. SS is Chief Product Officer of Newsenselab. ASOG has nothing to disclose. LN contributed to advisory boards of Hormosan, Lilly, Novartis and TEVA, and received speaking fees from Allergan, Biogen, Hormosan, Lilly, Novartis and TEVA. UR received honoraria for consulting and lectures from Amgen, Allergan, Abbvie, Eli Lilly, Lundbeck, Novartis Pharma, electroCore, Medscape, Novartis, StreaMedUp, and Teva; UR received research funding from BMBF and Novartis Pharma.